Title: Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective
year: 2016
Journal: J Clin Psychiatry
Volume: 77
Issue: 11
Pages: e1447-e1453
Epubdate: 14/10/2016
date: Nov
Alternate Journal: The Journal of clinical psychiatry
ISSN: 0160-6689
Article Number: 27736048
Abstract: OBJECTIVE: Early symptomatic response is pertinent in improving outcomes in first-episode psychosis. One of the ways in which this may be achieved is by reducing inappropriate delays in clozapine initiation. This study aimed to examine clozapine prescribing practices among clinicians by establishing the prevalence of clozapine use, identifying baseline clinical and demographic factors that were associated with clozapine use, examining outcomes in clozapine users versus nonusers, and identifying inappropriate antipsychotic prescription patterns prior to clozapine initiation. METHODS: A retrospective study including all consecutive patients who had presented to the Singapore Early Psychosis Intervention Programme (EPIP) from April 2001 to June 2012 was conducted. Clinical and demographic data were extracted from the EPIP database. Incident cases of clozapine users were identified, and additional treatment histories were obtained from medical records. In addition to descriptive statistics, multivariate analysis was performed to identify factors associated with clozapine initiation. RESULTS: Data from 1,603 patients were available for baseline analyses. Of these, 69 patients (4.3%) had been prescribed clozapine. Having a younger age at onset, lack of employment, a lower Global Assessment of Functioning disability score, and a higher Positive and Negative Syndrome Scale total score at baseline were factors associated with clozapine use. After adjustment was made for confounders, clozapine users were found to have attained similar rates of remission and recovery as patients who did not use clozapine. Clozapine initiation was delayed by a mean of 19.3 weeks (SD = 27.1; range, 0-117). Prior to commencing clozapine, 29.4% of patients had received antipsychotic treatments above maximum limits, whereas 75% of patients were prescribed >/= 3 different antipsychotics (median = 3; range, 2-7). CONCLUSIONS: This study has confirmed that the prescribing of clozapine is low, delayed, and preceded by dosing of antipsychotic drugs above maximum limits. Identification of the factors found to be associated with clozapine use may encourage clinicians to consider clozapine sooner in relevant patients in hopes of achieving early symptomatic response.
Notes: 1555-2101 Tang, Charmaine Subramaniam, Mythily Ng, Boon Tat Abdin, Edimansyah Poon, Lye Yin Verma, Swapna K Journal Article United States J Clin Psychiatry. 2016 Nov;77(11):e1447-e1453. doi: 10.4088/JCP.15m10063.
URI: https://open-access.imh.com.sg/handle/123456789/5084
Authors Address: Department of Early Psychosis Intervention, Institute of Mental Health, 10 Buangkok View Singapore 539747, Singapore. charmaine_yz_tang@imh.com.sg. Department of Early Psychosis Intervention, Institute of Mental Health, Singapore. Research Division, Institute of Mental Health, Singapore. Pharmacy Department, Institute of Mental Health, Singapore.
Database Provider: NLM
language: eng
Appears in Collections:2016

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.